NCT05173064

Brief Summary

The goal of the study is to confirm the idea of AI-powered Technological Surrogate Physiotherapist (TSP), by demonstrating its effectiveness and value as a new technology-based contribution to OA healthcare. Participants will be randomized to one of three groups: (1) the conventional PT group receiving the exercise program delivered through in-person sessions; (2) the AI-guided group following the program through the TSP after an initial PT session; or (3) the combined group receiving both in-person PT sessions and AI-guided home exercise. All individuals will take part in the study for 12 weeks, and data will be collected at baseline and 12 weeks after randomization.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
264

participants targeted

Target at P75+ for not_applicable pain

Timeline
11mo left

Started Oct 2025

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Oct 2025Mar 2027

First Submitted

Initial submission to the registry

December 9, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
3.8 years until next milestone

Study Start

First participant enrolled

October 30, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

October 7, 2025

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

December 9, 2021

Last Update Submit

October 1, 2025

Conditions

Keywords

knee pain, physical therapy, exercise

Outcome Measures

Primary Outcomes (2)

  • Changes in knee pain as assessed by a 11-point numerical pain rating scale as recommended by the OARSI

    0 represents no pain and 10 represents the worst possible pain.

    From baseline to 12 weeks

  • Changes in physical function as assessed by the Knee Injury and Osteoarthritis Outcome Score (KOOS) physical function sub-scale

    The scale regards the degree of difficulty in performing usual daily activities and higher level activities that involve physical function of the knee. Each item will be rated on a 5-point Likert scale ranging from 'None' (i.e., no difficulty) to 'Extreme' (i.e., extreme difficulty), based on which a normalized total score will be calculated (0 indicating extreme symptoms and 100 indicating no symptoms).

    From baseline to 12 weeks

Secondary Outcomes (8)

  • Changes in physical function as assessed by 30-second chair-stand test

    From baseline to 12 weeks

  • Changes in physical function as assessed by timed up-and-go test

    From baseline to 12 weeks

  • Changes in physical function as assessed by maximal isometric strength of the quadriceps and hamstrings

    From baseline to 12 weeks

  • Changes in physical function as assessed by active and passive ranges of motion of the hip and knee joints

    From baseline to 12 weeks

  • Changes in health-related quality of life assessed by the Chinese version of the 36-item Short Form Survey (SF-36)

    From baseline to 12 weeks

  • +3 more secondary outcomes

Study Arms (3)

The AI-powered Technological Surrogate Physiotherapist

EXPERIMENTAL

Participants will be required to perform three 30-minute exercise sessions per week for 12 weeks, with six exercises at any one time. During the exercise sessions, participants will receiveTechnological Surrogate Physiotherapist (TSP) support which will in particular leverage AI to offer innovative features and modules dedicated to enhancing exercise monitoring and supervision, real-time performance feedback, and self-assessment.

Device: The AI-powered Technological Surrogate Physiotherapist

Face-to-face physiotherapist-supervised exercise program

ACTIVE COMPARATOR

Participants will be required to visit a physiotherapist for usual face-to-face exercise therapy. Also, they will be required to perform three 30-minute home exercise sessions per week for 12 weeks. However, TSP will not be involved in this group.

Behavioral: Face-to-face physiotherapist-supervised exercise program

The AI-powered Technological Surrogate Physiotherapist Plus Face-to-face physiotherapist-supervised

EXPERIMENTAL

Participants will receive an integrated intervention combining conventional physiotherapist-supervised sessions and TSP-supported home exercises (three 30-minute exercise sessions per week for 12 weeks).

Combination Product: The AI-powered Technological Surrogate Physiotherapist Plus Face-to-face physiotherapist-supervised exercise program

Interventions

The AI-powered Technological Surrogate Physiotherapist will have three key features: 1. Evidence-based exercise videos instructed by physical therapists 2. Real-time movement feedback and performance score 3. Exercise records.

The AI-powered Technological Surrogate Physiotherapist

Physiotherapists will give usual face-to-face therapy. The assessment of participants' exercise movements will only be achieved in the traditional manner during face-to-face exercise sessions - by physiotherapists' visual inspection of and professional judgement on postural alignment and effectiveness, with verbal instructions for posture correction. The features of real-time movement feedback and tracking of exercise progress will not be provided.

Face-to-face physiotherapist-supervised exercise program

This group will attend in-person group therapy sessions, while additionally completing weekly home exercise sessions using the TSP system.

The AI-powered Technological Surrogate Physiotherapist Plus Face-to-face physiotherapist-supervised

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be recruited if they
  • age ≥ 50 years,
  • report having pain in or around the knee for more than 12 weeks and on most days of the previous month,
  • report being diagnosed with knee OA by a physician, have physician-diagnosed knee OA in the medical record, or have radiographic evidence of grade 2 to 3 knee OA on the Kellgren-Lawrence scale in the posteroanterior and/or skyline view or the presence of lateral/posterior osteophytes (the X-rays will be read and classified by our orthopaedic surgeons collaborators to decide on each patient's eligibility to be included in the study),
  • are willing and physically and cognitively able to perform (technology-supported) exercises required in the study protocol
  • have normal or corrected to normal vision,
  • are able to speak and read Chinese,
  • are able to provide written informed consent.

You may not qualify if:

  • Individuals will be excluded if they have
  • history of knee or hip replacement surgery,
  • non-ambulatory status,
  • systemic inflammatory arthritis (e.g., gout),
  • history of trauma (e.g., fractures around the knee, dislocation, and sprains or tears of soft tissues, like ligaments) or surgical arthroscopy of either knee within the past 6 months,
  • intra-articular injection to the knee within the past 6 months,
  • cognitive impairment,
  • involvement in a similar study in the past 6 months,
  • recent or imminent surgery (within 12 weeks),
  • medical co-morbidities that preclude participation in exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

826, Haking Wong Building, Pokfulam, The University of Hong Kong, Hong Kong

Hong Kong, 000, Hong Kong

Location

Related Publications (14)

  • Roberts JM, Wilson K. Effect of stretching duration on active and passive range of motion in the lower extremity. Br J Sports Med. 1999 Aug;33(4):259-63. doi: 10.1136/bjsm.33.4.259.

    PMID: 10450481BACKGROUND
  • Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. doi: 10.1111/j.1532-5415.1991.tb01616.x.

    PMID: 1991946BACKGROUND
  • Hinman RS, Kimp AJ, Campbell PK, Russell T, Foster NE, Kasza J, Harris A, Bennell KL. Technology versus tradition: a non-inferiority trial comparing video to face-to-face consultations with a physiotherapist for people with knee osteoarthritis. Protocol for the PEAK randomised controlled trial. BMC Musculoskelet Disord. 2020 Aug 7;21(1):522. doi: 10.1186/s12891-020-03523-8.

    PMID: 32767989BACKGROUND
  • Lam CL, Tse EY, Gandek B, Fong DY. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol. 2005 Aug;58(8):815-22. doi: 10.1016/j.jclinepi.2004.12.008.

    PMID: 16018917BACKGROUND
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PMID: 1593914BACKGROUND
  • Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, Buchbinder R, Snyder-Mackler L, Henrotin Y, Thumboo J, Hansen P, Bennell KL. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthritis Cartilage. 2013 Aug;21(8):1042-52. doi: 10.1016/j.joca.2013.05.002. Epub 2013 May 13.

    PMID: 23680877BACKGROUND
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.

    PMID: 22588748BACKGROUND
  • McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, Wang S, Schnitzer T. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthritis Cartilage. 2015 May;23(5):747-60. doi: 10.1016/j.joca.2015.03.005.

    PMID: 25952346BACKGROUND
  • McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. Br J Rheumatol. 1992 Mar;31(3):189-92. doi: 10.1093/rheumatology/31.3.189.

    PMID: 1540789BACKGROUND
  • Cottrell E, Roddy E, Foster NE. The attitudes, beliefs and behaviours of GPs regarding exercise for chronic knee pain: a systematic review. BMC Fam Pract. 2010 Jan 18;11:4. doi: 10.1186/1471-2296-11-4.

    PMID: 20082694BACKGROUND
  • Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Patel A, Williamson E, Jones RH, Dieppe PA, Reeves BC. Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum. 2007 Oct 15;57(7):1211-9. doi: 10.1002/art.22995.

    PMID: 17907147BACKGROUND
  • Hurley MV, Walsh NE, Mitchell H, Nicholas J, Patel A. Long-term outcomes and costs of an integrated rehabilitation program for chronic knee pain: a pragmatic, cluster randomized, controlled trial. Arthritis Care Res (Hoboken). 2012 Feb;64(2):238-47. doi: 10.1002/acr.20642.

    PMID: 21954131BACKGROUND
  • Chen T, Or CK, Chen J. Effects of technology-supported exercise programs on the knee pain, physical function, and quality of life of individuals with knee osteoarthritis and/or chronic knee pain: A systematic review and meta-analysis of randomized controlled trials. J Am Med Inform Assoc. 2021 Feb 15;28(2):414-423. doi: 10.1093/jamia/ocaa282.

    PMID: 33236109BACKGROUND
  • Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, Blenkinsopp A, Sim J. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ. 2006 Nov 11;333(7576):995. doi: 10.1136/bmj.38977.590752.0B. Epub 2006 Oct 20.

    PMID: 17056608BACKGROUND

MeSH Terms

Conditions

PainOsteoarthritis, KneeMotor Activity

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavior

Central Study Contacts

Calvin Kalun Or, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2021

First Posted

December 29, 2021

Study Start

October 30, 2025

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

October 7, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations